Annovis Bio, Inc. - stock earnings
ANVS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -14.7 million USD | ? USD |
| 2023Q2 | -9.5 million USD | ? USD |
| 2023Q1 | -29.4 million USD | ? USD |
| 2022Q4 | -3.0 million USD | ? USD |
| 2022Q3 | -7.5 million USD | ? USD |
| 2022Q2 | -8.6 million USD | ? USD |
| 2022Q1 | -5.9 million USD | ? USD |
| 2021Q4 | -5.9 million USD | ? USD |
| 2021Q3 | -2.8 million USD | ? USD |
| 2021Q2 | -2.5 million USD | ? USD |
| 2021Q1 | -3.2 million USD | ? USD |
| 2020Q4 | -1.7 million USD | ? USD |
| 2020Q3 | -1.0 million USD | ? USD |
| 2020Q2 | -2.3 million USD | ? USD |
| 2020Q1 | -441590 USD | ? USD |
| 2019Q4 | -201256 USD | ? USD |
| 2019Q3 | -254121 USD | ? USD |
| 2019Q2 | -344700 USD | ? USD |
| 2019Q1 | -190903 USD | ? USD |
| 2018Q4 | -168051 USD | ? USD |
| 2018Q3 | -137734 USD | ? USD |
| 2018Q2 | -218146 USD | ? USD |
| 2018Q1 | -189940 USD | ? USD |
| 2013Q3 | -382216 USD | 6870 USD |
| 2013Q2 | -402655 USD | 21061 USD |
| 2013Q1 | -148959 USD | 179875 USD |
| 2012Q4 | -1.1 million USD | 158850 USD |
ANVS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -41.7 million USD | ? USD |
| 2022 | -25.1 million USD | ? USD |
| 2021 | -14.4 million USD | ? USD |
| 2020 | -4.3 million USD | ? USD |
| 2019 | -296838 USD | ? USD |
| 2018 | -713871 USD | ? USD |
| 2017 | -682349 USD | ? USD |
| 2012 | -8.3 million USD | 185175 USD |
| 2011 | -4.7 million USD | ? USD |
| 2010 | -1.3 million USD | 7.2 million USD |
| 2009 | -369579 USD | 15717 USD |
ANVS
Price: $18.01
52 week price:
Earnings Per Share: -6.23 USD
P/E Ratio: -2.06
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 103127
Market Capitalization: 128.1 million